Share on StockTwits

Cambrex Corp. (NYSE:CBM) is scheduled to be announcing its Q114 earnings results on Friday, May 2nd. Analysts expect the company to announce earnings of $0.23 per share and revenue of $79.40 million for the quarter. Cambrex Corp. has set its FY14 guidance at $0.99-1.10 EPS.Parties that are interested in registering for the company’s conference call can do so using this link.

Cambrex Corp. (NYSE:CBM) last released its earnings data on Tuesday, February 11th. The company reported $0.30 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.30. The company had revenue of $103.00 million for the quarter, compared to the consensus estimate of $95.25 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 46.3% on a year-over-year basis. On average, analysts expect Cambrex Corp. to post $1.03 EPS for the current fiscal year and $1.26 EPS for the next fiscal year.

Shares of Cambrex Corp. (NYSE:CBM) opened at 20.49 on Thursday. Cambrex Corp. has a 52-week low of $11.82 and a 52-week high of $22.34. The stock’s 50-day moving average is $19.87 and its 200-day moving average is $18.8. The company has a market cap of $624.6 million and a price-to-earnings ratio of 24.53.

Cambrex Corporation (NYSE:CBM) is a life sciences company, which provides products and services, which accelerate and improve the development and commercialization of new and generic therapeutics.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.